Evidence map›Paper›PMID 33829678›Full record

ReviewAdvanced healthcare materials2021

Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration.

Lars Crawford, Meghan Wyatt, James Bryers, Buddy Ratner

Abstract readReview
In one paragraph

Review in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. [Applications of novel biomaterials in the research and treatment of allergic rhinitis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Beyond Killing: The Overlooked Contribution of Neutrophils to Tissue Repair.International journal of molecular sciences · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Engineering the Immune Response to Biomaterials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lars CrawfordDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
Meghan WyattDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
James BryersDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.
Buddy RatnerDepartment of Bioengineering, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0001-5233-2216

Funding

Periodontal Biomaterials with BITE (Biofilm Immunity with Tissue Engineering)R01DE018701 · NIDCR · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2008 to 2019
$5.0M
Tissue Regeneration by Engineered Extracellular VesiclesR01GM128991 · NIGMS · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2019 to 2022
$1.9M
NIDCR NIH HHS R01 DE018701NIGMS NIH HHS R01 GM128991
6 · The paper itself

Abstract

The word "biocompatibility," is inconsistent with the observations of healing for so-called biocompatible biomaterials. The vast majority of the millions of medical implants in humans today, presumably "biocompatible," are walled off by a dense, avascular, crosslinked collagen capsule, hardly suggestive of life or compatibility. In contrast, one is now seeing examples of implant biomaterials that lead to a vascularized reconstruction of localized tissue, a biological reaction different from traditional biocompatible materials that generate a foreign body capsule. Both the encapsulated biomaterials and the reconstructive biomaterials qualify as "biocompatible" by present day measurements of biocompatibility. Yet, this new generation of materials would seem to heal "compatibly" with the living organism, where older biomaterials are isolated from the living organism by the dense capsule. This review/perspective article will explore this biocompatibility etymological conundrum by reviewing the history of the concepts around biocompatibility, today's standard methods for assessing biocompatibility, a contemporary view of the foreign body reaction and finally, a compendium of new biomaterials that heal without the foreign body capsule. A new definition of biocompatibility is offered here to address advances in biomaterials design leading to biomaterials that heal into the body in a facile manner.

Indexed as

Biocompatible MaterialsForeign-Body ReactionHumansProstheses and ImplantsWound HealingBiocompatible Materialsbiocompatibilitybiointegrationbiomaterialshealingtoxicology

Identifiers

PMID33829678
PMCPMC8221530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.